Stocksigma LogoStocksigma Logo

Pharmaids Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs)

■ Revenue: 434 (-49.6% YoY | +5.2% QoQ) ■ EBITDA: -128 (+78.7% YoY | -72.4% QoQ) ■ EBITDA Margin (%): -29.6 (+4039 bps YoY | -1154 bps QoQ) ■ PAT: -210

Pharmaids Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs)

Pharmaids Pharmaceuticals Ltd · Outcome · 12 Nov 2026, 12:53 am

Pharmaids Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs) ■ Revenue: 434 (-49.6% YoY | +5.2% QoQ) ■ EBITDA: -128 (+78.7% YoY | -72.4% QoQ) ■ EBITDA Margin (%): -29.6 (+4039 bps YoY | -1154 bps QoQ) ■ PAT: -210 (+34.0% YoY | Profit to Loss QoQ) ■ EPS (INR): -0.60 (+33.3% YoY | Profit to Loss QoQ)

Original exchange filing (PDF)

More announcements from Pharmaids Pharmaceuticals Ltd

All Pharmaids Pharmaceuticals Ltd announcements